a female doctor holding a chart and explaining something to a woman and a man
Syndromic Testing

Faster answers, better care

Help your patients lead healthier, happier lives 

Why did you go into medicine? Was it to improve the health of your community? To bring new life into the world? To give yourself an intellectual challenge? Whatever your motivation, the outcome is the same: You help others because #LifeMatters to you.

Now, let us help you by taking the guesswork out of your diagnostics.

With our fully automated diagnostic systems, we can help you get the answers you need, right when you need them. So you can help your patients get better, faster, and accomplish #WhatMatters to you.

Be more certain in your diagnosis

With multiplex polymerase chain reaction (PCR) panel testing for infectious diseases, there’s no longer any need to guess. In about an hour, you can get results for 20 or more pathogens. These tests show better analytical sensitivity than traditional methods and reduce the need for retesting, as more pathogens are detected the first time (1–4). 

And multiplex PCR assays are recommended by a number of international medical bodies for certain disease states (5). 

How can you make better-informed decisions for your patients?
Read the flyer to learn how.
Get the flyer

Give your patients the care they deserve

Your patients with infectious diseases need more than just medical treatment. They want you to tell them what’s making them sick and reassurance that the best course of action is being taken. If you don’t think they need an antibiotic, they need to know why. With multiplex PCR panel testing, you can give them a better experience by supplying them with a definitive answer.

But it’s not just about patient satisfaction. Multiplex PCR panel testing provides real, tangible benefits for patients by enabling better patient management:

Better outcomes
Better outcomes
Reduced mortality in the ICU (6) 
Shorter length of stay
Shorter length of stay
Significant reduction in length of stay for individuals with infectious illnesses (7–10)
Less overall testing
Less overall testing
Reduced need for multiple rounds of testing thanks to broader pathogen coverage (2, 3, 7, 8, 11–13)
Earlier cohorting
Earlier cohorting
Improved cohorting of individuals with symptoms of infectious illness and improved infection control (9, 14)

Strengthen antimicrobial stewardship

Global antimicrobial resistance is growing, and the WHO lists resistance as one of the world’s most significant health threats. But evidence-based diagnostics can help us fight back. By knowing your enemy, you can use antibiotics more deliberately. Multiplex PCR panel tests are helping healthcare providers optimize their antibiotic use:

Shorter duration of antibiotic use
Shorter duration of antibiotic use
Fewer days of antibiotic use in individuals with infectious illnesses (15)
Optimized antibiotic prescription
Optimized antibiotic prescription
More appropriate prescription of oseltamivir in individuals diagnosed with influenza (12) 
Optimized antibiotic discontinuation
Optimized antibiotic discontinuation
Reversed antibiotic prescriptions in many cases (11, 13)
hospital icon

Save on costs

The institutional savings start to add up when hospital admission, isolation procedures and antibiotic prescriptions are used more shrewdly. Several studies have shown that multiplex PCR panel testing can save on overall healthcare costs (2, 6, 8).

Get back to basics 

Want to learn more about how multiplex PCR testing works and how it can revolutionize the way you do medicine? Visit our resource hub to find infographics, recommended reading and more.
Show me
patient, girl, mother, daughter, doctor, doctor's

How are other healthcare providers using multiplex PCR assays?

QIAstat-Dx is our answer to fast and convenient multiplex PCR assays. Learn how infectious disease experts are using QIAstat-Dx to improve diagnostics at their institutions around the world.
Read their opinions

Take your testing on the go 

What if you could get a birds-eye-view of test status anytime, anywhere? It’s possible with QIAstat-Dx connectivity, powered by QIAsphere. Keep an eye on your testing with QIAstat-Dx’s bidirectional LIMS integration and suite of connectivity features. Learn more in our connectivity guide.
Get connected
QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge QIAstat-Dx, QIAstat-Dx analyzer, syndromic testing, instrument, cartridge, technician, woman, lab tech, lab, laboratory

Discover our small but mighty multiplex PCR platform 

The QIAstat-Dx Analyzer offers results for multiple bacterial and viral pathogens using just a single patient sample – all in about an hour. We think the QIAstat-Dx can revolutionize the way you do medicine.
Tell me more

Your compass for disease incidence and prevalence

Confidently navigate the ebb and flow of infectious diseases in your community – and beyond – with QIAsphere Insights. Track everything from pathogen diversity, to rates of co-detection, to Ct value measures. With QIAsphere Insights, the power of epidemiology is in your hands.

Discover the Insights dashboard
Q-Solutions Magazine
Give your patients better care with PCR panel testing
Contact us today to learn how we can help.
Get in touch
Meet us at events and conferences
Meet us at events and conferences
See what conferences we’ll be attending and what events we’ll be hosting for you throughout the year.
Check out events
Explore our library of webinars
Explore our library of webinars
Watch our most recent webinars to learn how experts have incorporated our infectious disease diagnostic solution into their diagnostic approach. 
Watch webinars
Dive into articles
Dive into articles
Get the latest information on syndromic testing for infectious diseases, including insights on new publications and developments.
Read articles
References
  1. Yalamanchili H, et al. Gastroenterol Hepatol (N Y). 2018;14(11):646-652.
  2. Binnicker MJ. J Clin Microbiol. 2015;53(12):3723-3728.
  3. Axelrad JE, et al. J Clin Microbiol. 2019;57(3):e01775-18.
  4. Gelfer G, et al. Diagn Microbiol Infect Dis. 2015;83(4):400-406.
  5. Academy of Medical Science (2021) COVID-19: Preparing for the future – Looking ahead to winter 2021/22 and beyond. https://acmedsci.ac.uk/file-download/4747802
  6. Martinez, RM, et al. Poster #C-368 presented at: Clinical Virology Symposium. 2016.
  7. Beal SG, et al. J Clin Microbiol. 2017;56(1):e01457-17.
  8. Kitano T, et al. J Infect Chemother. 2020;26(1):82-85.
  9. Rogers BB, et al. Arch Pathol Lab Med. 2015;139(5):636-641.
  10. Zhu C, et al. Clin Pediatr (Phila). 2019;58(2):185-190.
  11. Castany-Feixas M, et al. Eur J Clin Microbiol Infect Dis. 2021;40(10):2153-2160. *
  12. Echavarría M, et al. J Clin Virol. 2018;108:90-95.
  13. Hansen LH, et al. Acta Paediatr. 2022;111(11):2195-2202. *
  14. Brendish NJ, et al. Lancet Respir Med. 2020;8(12):1192-1200. *
  15. Zhu C, et al. Clin Pediatr (Phila). 2019;58(2):185-190.


Unless otherwise indicated, data cited pertains to the use of a device from another manufacturer.

* Study performed using the QIAstat-Dx Analyzer 1.0.

The QIAstat-Dx Analyzer and QIAstat-Dx panels are intended for in vitro diagnostic use.

Product availability may differ from country to country based on regulations and approvals. Contact your country representative for further details.

For up-to-date licensing information and product-specific disclaimers, see the respective QIAGEN kit instructions for use or user manual. QIAGEN instructions for use and user manuals are available at www.qiagen.com or can be requested from QIAGEN Technical Services (or your local distributor).